nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitotane—FDX1—Endogenous sterols—CYP46A1—Alzheimer's disease	0.0323	0.112	CbGpPWpGaD
Mitotane—Cutaneous hypersensitivity—Rivastigmine—Alzheimer's disease	0.0172	0.0255	CcSEcCtD
Mitotane—FDX1—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	0.015	0.0522	CbGpPWpGaD
Mitotane—Movement disorder—Rivastigmine—Alzheimer's disease	0.0139	0.0206	CcSEcCtD
Mitotane—FDX1—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	0.0122	0.0423	CbGpPWpGaD
Mitotane—Retinal disorder—Rivastigmine—Alzheimer's disease	0.0118	0.0174	CcSEcCtD
Mitotane—CYP11B1—Endogenous sterols—CYP46A1—Alzheimer's disease	0.0115	0.0401	CbGpPWpGaD
Mitotane—Hyperpyrexia—Rivastigmine—Alzheimer's disease	0.0113	0.0167	CcSEcCtD
Mitotane—Hepatitis cholestatic—Memantine—Alzheimer's disease	0.0107	0.0158	CcSEcCtD
Mitotane—CYP11A1—Endogenous sterols—CYP46A1—Alzheimer's disease	0.00985	0.0343	CbGpPWpGaD
Mitotane—Trauma—Rivastigmine—Alzheimer's disease	0.00882	0.0131	CcSEcCtD
Mitotane—Balance disorder—Memantine—Alzheimer's disease	0.00785	0.0117	CcSEcCtD
Mitotane—Balance disorder—Rivastigmine—Alzheimer's disease	0.00768	0.0114	CcSEcCtD
Mitotane—SHBG—Nongenotropic Androgen signaling—PLCB1—Alzheimer's disease	0.00765	0.0266	CbGpPWpGaD
Mitotane—FDX1—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.00726	0.0253	CbGpPWpGaD
Mitotane—Aggression—Galantamine—Alzheimer's disease	0.00694	0.0103	CcSEcCtD
Mitotane—Encephalopathy—Memantine—Alzheimer's disease	0.00668	0.00992	CcSEcCtD
Mitotane—Hypothyroidism—Memantine—Alzheimer's disease	0.00668	0.00992	CcSEcCtD
Mitotane—FDX1—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	0.00665	0.0232	CbGpPWpGaD
Mitotane—Hypothyroidism—Rivastigmine—Alzheimer's disease	0.00654	0.00971	CcSEcCtD
Mitotane—FDX1—Biological oxidations—CYP46A1—Alzheimer's disease	0.00646	0.0225	CbGpPWpGaD
Mitotane—Hepatic enzyme increased—Galantamine—Alzheimer's disease	0.00645	0.00957	CcSEcCtD
Mitotane—Cataract—Galantamine—Alzheimer's disease	0.00641	0.00951	CcSEcCtD
Mitotane—Albuminuria—Donepezil—Alzheimer's disease	0.00633	0.0094	CcSEcCtD
Mitotane—Fungal infection—Donepezil—Alzheimer's disease	0.00612	0.00908	CcSEcCtD
Mitotane—Salivary hypersecretion—Galantamine—Alzheimer's disease	0.00592	0.00879	CcSEcCtD
Mitotane—Dermatitis atopic—Rivastigmine—Alzheimer's disease	0.00567	0.00842	CcSEcCtD
Mitotane—Albuminuria—Rivastigmine—Alzheimer's disease	0.00562	0.00835	CcSEcCtD
Mitotane—Fungal infection—Memantine—Alzheimer's disease	0.00556	0.00825	CcSEcCtD
Mitotane—FDX1—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.0055	0.0191	CbGpPWpGaD
Mitotane—Fungal infection—Rivastigmine—Alzheimer's disease	0.00544	0.00807	CcSEcCtD
Mitotane—FDX1—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.00539	0.0188	CbGpPWpGaD
Mitotane—Aggression—Donepezil—Alzheimer's disease	0.00538	0.00798	CcSEcCtD
Mitotane—CYP11B1—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	0.00535	0.0186	CbGpPWpGaD
Mitotane—CYP11B1—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	0.00528	0.0184	CbGpPWpGaD
Mitotane—Endocrine disorder—Memantine—Alzheimer's disease	0.00518	0.00768	CcSEcCtD
Mitotane—Dysarthria—Donepezil—Alzheimer's disease	0.005	0.00742	CcSEcCtD
Mitotane—Hypercholesterolaemia—Donepezil—Alzheimer's disease	0.005	0.00742	CcSEcCtD
Mitotane—Speech disorder—Memantine—Alzheimer's disease	0.00499	0.00741	CcSEcCtD
Mitotane—Cataract—Donepezil—Alzheimer's disease	0.00496	0.00737	CcSEcCtD
Mitotane—Aggression—Memantine—Alzheimer's disease	0.00488	0.00725	CcSEcCtD
Mitotane—Speech disorder—Rivastigmine—Alzheimer's disease	0.00488	0.00724	CcSEcCtD
Mitotane—Injury—Galantamine—Alzheimer's disease	0.00482	0.00715	CcSEcCtD
Mitotane—Aggression—Rivastigmine—Alzheimer's disease	0.00478	0.00709	CcSEcCtD
Mitotane—Salivary hypersecretion—Donepezil—Alzheimer's disease	0.00459	0.00681	CcSEcCtD
Mitotane—CYP11A1—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	0.00457	0.0159	CbGpPWpGaD
Mitotane—FDX1—nervous system—Alzheimer's disease	0.00457	0.134	CbGeAlD
Mitotane—Dyskinesia—Memantine—Alzheimer's disease	0.00457	0.00678	CcSEcCtD
Mitotane—Hypercholesterolaemia—Memantine—Alzheimer's disease	0.00454	0.00673	CcSEcCtD
Mitotane—Hepatic enzyme increased—Memantine—Alzheimer's disease	0.00454	0.00673	CcSEcCtD
Mitotane—Lethargy—Galantamine—Alzheimer's disease	0.00452	0.00671	CcSEcCtD
Mitotane—CYP11A1—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	0.00451	0.0157	CbGpPWpGaD
Mitotane—Cataract—Memantine—Alzheimer's disease	0.00451	0.00669	CcSEcCtD
Mitotane—Dyskinesia—Rivastigmine—Alzheimer's disease	0.00447	0.00663	CcSEcCtD
Mitotane—Hypercholesterolaemia—Rivastigmine—Alzheimer's disease	0.00444	0.00659	CcSEcCtD
Mitotane—Dysarthria—Rivastigmine—Alzheimer's disease	0.00444	0.00659	CcSEcCtD
Mitotane—Cataract—Rivastigmine—Alzheimer's disease	0.00441	0.00655	CcSEcCtD
Mitotane—FDX1—central nervous system—Alzheimer's disease	0.0044	0.129	CbGeAlD
Mitotane—CYP11B1—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	0.00433	0.0151	CbGpPWpGaD
Mitotane—FDX1—cerebellum—Alzheimer's disease	0.0043	0.126	CbGeAlD
Mitotane—SHBG—Nongenotropic Androgen signaling—CREB1—Alzheimer's disease	0.00419	0.0146	CbGpPWpGaD
Mitotane—Ataxia—Galantamine—Alzheimer's disease	0.00416	0.00618	CcSEcCtD
Mitotane—Salivary hypersecretion—Rivastigmine—Alzheimer's disease	0.00408	0.00605	CcSEcCtD
Mitotane—Orthostatic hypotension—Galantamine—Alzheimer's disease	0.00404	0.006	CcSEcCtD
Mitotane—Muscular weakness—Galantamine—Alzheimer's disease	0.0039	0.0058	CcSEcCtD
Mitotane—Neoplasm—Memantine—Alzheimer's disease	0.00388	0.00576	CcSEcCtD
Mitotane—FDX1—Biological oxidations—MAOB—Alzheimer's disease	0.00386	0.0134	CbGpPWpGaD
Mitotane—Neoplasm—Rivastigmine—Alzheimer's disease	0.0038	0.00563	CcSEcCtD
Mitotane—Injury—Donepezil—Alzheimer's disease	0.00373	0.00554	CcSEcCtD
Mitotane—Mental disability—Memantine—Alzheimer's disease	0.00372	0.00553	CcSEcCtD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	0.00372	0.0129	CbGpPWpGaD
Mitotane—CYP11A1—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	0.00371	0.0129	CbGpPWpGaD
Mitotane—Mental disability—Rivastigmine—Alzheimer's disease	0.00364	0.00541	CcSEcCtD
Mitotane—CYP11A1—Prostaglandin Synthesis and Regulation—PTGS1—Alzheimer's disease	0.0036	0.0125	CbGpPWpGaD
Mitotane—FDX1—brain—Alzheimer's disease	0.00349	0.102	CbGeAlD
Mitotane—Osteoarthritis—Donepezil—Alzheimer's disease	0.00343	0.00509	CcSEcCtD
Mitotane—Injury—Memantine—Alzheimer's disease	0.00339	0.00503	CcSEcCtD
Mitotane—Amnesia—Memantine—Alzheimer's disease	0.00332	0.00492	CcSEcCtD
Mitotane—Injury—Rivastigmine—Alzheimer's disease	0.00332	0.00492	CcSEcCtD
Mitotane—Irritability—Donepezil—Alzheimer's disease	0.00327	0.00486	CcSEcCtD
Mitotane—Haematuria—Galantamine—Alzheimer's disease	0.00325	0.00483	CcSEcCtD
Mitotane—Amnesia—Rivastigmine—Alzheimer's disease	0.00324	0.00481	CcSEcCtD
Mitotane—Hepatobiliary disease—Galantamine—Alzheimer's disease	0.00323	0.00479	CcSEcCtD
Mitotane—Ataxia—Donepezil—Alzheimer's disease	0.00323	0.00479	CcSEcCtD
Mitotane—Lethargy—Memantine—Alzheimer's disease	0.00318	0.00472	CcSEcCtD
Mitotane—Orthostatic hypotension—Donepezil—Alzheimer's disease	0.00313	0.00465	CcSEcCtD
Mitotane—Diplopia—Memantine—Alzheimer's disease	0.00311	0.00462	CcSEcCtD
Mitotane—Osteoarthritis—Memantine—Alzheimer's disease	0.00311	0.00462	CcSEcCtD
Mitotane—Hepatitis—Galantamine—Alzheimer's disease	0.00306	0.00455	CcSEcCtD
Mitotane—Diplopia—Rivastigmine—Alzheimer's disease	0.00305	0.00452	CcSEcCtD
Mitotane—Osteoarthritis—Rivastigmine—Alzheimer's disease	0.00305	0.00452	CcSEcCtD
Mitotane—Muscular weakness—Donepezil—Alzheimer's disease	0.00303	0.00449	CcSEcCtD
Mitotane—Urinary tract disorder—Galantamine—Alzheimer's disease	0.00302	0.00449	CcSEcCtD
Mitotane—Connective tissue disorder—Galantamine—Alzheimer's disease	0.00301	0.00447	CcSEcCtD
Mitotane—Urethral disorder—Galantamine—Alzheimer's disease	0.003	0.00446	CcSEcCtD
Mitotane—Irritability—Memantine—Alzheimer's disease	0.00297	0.00441	CcSEcCtD
Mitotane—Visual impairment—Galantamine—Alzheimer's disease	0.00295	0.00438	CcSEcCtD
Mitotane—Ataxia—Memantine—Alzheimer's disease	0.00293	0.00435	CcSEcCtD
Mitotane—FDX1—Biological oxidations—PTGS1—Alzheimer's disease	0.00292	0.0102	CbGpPWpGaD
Mitotane—FDX1—Biological oxidations—CYP2D6—Alzheimer's disease	0.00287	0.00997	CbGpPWpGaD
Mitotane—Ataxia—Rivastigmine—Alzheimer's disease	0.00287	0.00425	CcSEcCtD
Mitotane—Eye disorder—Galantamine—Alzheimer's disease	0.00286	0.00425	CcSEcCtD
Mitotane—Orthostatic hypotension—Memantine—Alzheimer's disease	0.00284	0.00422	CcSEcCtD
Mitotane—Flushing—Galantamine—Alzheimer's disease	0.00284	0.00422	CcSEcCtD
Mitotane—Orthostatic hypotension—Rivastigmine—Alzheimer's disease	0.00278	0.00413	CcSEcCtD
Mitotane—Angiopathy—Galantamine—Alzheimer's disease	0.00278	0.00412	CcSEcCtD
Mitotane—Breast disorder—Rivastigmine—Alzheimer's disease	0.00275	0.00409	CcSEcCtD
Mitotane—Muscular weakness—Memantine—Alzheimer's disease	0.00275	0.00408	CcSEcCtD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	0.00269	0.00936	CbGpPWpGaD
Mitotane—Muscular weakness—Rivastigmine—Alzheimer's disease	0.00269	0.00399	CcSEcCtD
Mitotane—Mental disorder—Galantamine—Alzheimer's disease	0.00268	0.00398	CcSEcCtD
Mitotane—Malnutrition—Galantamine—Alzheimer's disease	0.00267	0.00396	CcSEcCtD
Mitotane—Infestation NOS—Donepezil—Alzheimer's disease	0.00264	0.00392	CcSEcCtD
Mitotane—Infestation—Donepezil—Alzheimer's disease	0.00264	0.00392	CcSEcCtD
Mitotane—Dysgeusia—Galantamine—Alzheimer's disease	0.00261	0.00388	CcSEcCtD
Mitotane—CYP11B1—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.00259	0.009	CbGpPWpGaD
Mitotane—Haematuria—Donepezil—Alzheimer's disease	0.00252	0.00374	CcSEcCtD
Mitotane—Neutropenia—Memantine—Alzheimer's disease	0.00252	0.00374	CcSEcCtD
Mitotane—Vision blurred—Galantamine—Alzheimer's disease	0.00251	0.00373	CcSEcCtD
Mitotane—Tremor—Galantamine—Alzheimer's disease	0.0025	0.00371	CcSEcCtD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	0.00248	0.00864	CbGpPWpGaD
Mitotane—Anaemia—Galantamine—Alzheimer's disease	0.00246	0.00366	CcSEcCtD
Mitotane—Infestation—Memantine—Alzheimer's disease	0.0024	0.00356	CcSEcCtD
Mitotane—Infestation NOS—Memantine—Alzheimer's disease	0.0024	0.00356	CcSEcCtD
Mitotane—Vertigo—Galantamine—Alzheimer's disease	0.00239	0.00356	CcSEcCtD
Mitotane—Hepatitis—Donepezil—Alzheimer's disease	0.00237	0.00352	CcSEcCtD
Mitotane—CYP11B1—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	0.00237	0.00825	CbGpPWpGaD
Mitotane—Infestation—Rivastigmine—Alzheimer's disease	0.00235	0.00349	CcSEcCtD
Mitotane—Infestation NOS—Rivastigmine—Alzheimer's disease	0.00235	0.00349	CcSEcCtD
Mitotane—Drowsiness—Rivastigmine—Alzheimer's disease	0.00235	0.00349	CcSEcCtD
Mitotane—Urinary tract disorder—Donepezil—Alzheimer's disease	0.00234	0.00348	CcSEcCtD
Mitotane—CYP11B1—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	0.00234	0.00814	CbGpPWpGaD
Mitotane—Urethral disorder—Donepezil—Alzheimer's disease	0.00233	0.00345	CcSEcCtD
Mitotane—CYP11B1—Biological oxidations—CYP46A1—Alzheimer's disease	0.0023	0.00801	CbGpPWpGaD
Mitotane—Hypertension—Galantamine—Alzheimer's disease	0.0023	0.00342	CcSEcCtD
Mitotane—Haematuria—Memantine—Alzheimer's disease	0.00229	0.0034	CcSEcCtD
Mitotane—Visual impairment—Donepezil—Alzheimer's disease	0.00229	0.00339	CcSEcCtD
Mitotane—CYP11B1—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.00227	0.0079	CbGpPWpGaD
Mitotane—Hepatobiliary disease—Memantine—Alzheimer's disease	0.00227	0.00337	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00225	0.00335	CcSEcCtD
Mitotane—Haematuria—Rivastigmine—Alzheimer's disease	0.00224	0.00332	CcSEcCtD
Mitotane—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.00222	0.0033	CcSEcCtD
Mitotane—CYP11A1—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.00221	0.0077	CbGpPWpGaD
Mitotane—Confusional state—Galantamine—Alzheimer's disease	0.00219	0.00326	CcSEcCtD
Mitotane—Hepatitis—Memantine—Alzheimer's disease	0.00215	0.0032	CcSEcCtD
Mitotane—Shock—Galantamine—Alzheimer's disease	0.00214	0.00318	CcSEcCtD
Mitotane—Nervous system disorder—Galantamine—Alzheimer's disease	0.00213	0.00317	CcSEcCtD
Mitotane—Thrombocytopenia—Galantamine—Alzheimer's disease	0.00213	0.00316	CcSEcCtD
Mitotane—Urinary tract disorder—Memantine—Alzheimer's disease	0.00213	0.00316	CcSEcCtD
Mitotane—Connective tissue disorder—Memantine—Alzheimer's disease	0.00212	0.00314	CcSEcCtD
Mitotane—Skin disorder—Galantamine—Alzheimer's disease	0.00211	0.00314	CcSEcCtD
Mitotane—Urethral disorder—Memantine—Alzheimer's disease	0.00211	0.00314	CcSEcCtD
Mitotane—Hepatitis—Rivastigmine—Alzheimer's disease	0.00211	0.00313	CcSEcCtD
Mitotane—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.00208	0.00309	CcSEcCtD
Mitotane—Mental disorder—Donepezil—Alzheimer's disease	0.00208	0.00309	CcSEcCtD
Mitotane—CYP11A1—nervous system—Alzheimer's disease	0.00208	0.0609	CbGeAlD
Mitotane—Visual impairment—Memantine—Alzheimer's disease	0.00208	0.00308	CcSEcCtD
Mitotane—Anorexia—Galantamine—Alzheimer's disease	0.00207	0.00308	CcSEcCtD
Mitotane—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.00207	0.00307	CcSEcCtD
Mitotane—Urethral disorder—Rivastigmine—Alzheimer's disease	0.00207	0.00307	CcSEcCtD
Mitotane—Malnutrition—Donepezil—Alzheimer's disease	0.00207	0.00307	CcSEcCtD
Mitotane—Mazindol—SLC6A4—Alzheimer's disease	0.00206	0.417	CrCbGaD
Mitotane—Hypotension—Galantamine—Alzheimer's disease	0.00203	0.00302	CcSEcCtD
Mitotane—Visual impairment—Rivastigmine—Alzheimer's disease	0.00203	0.00302	CcSEcCtD
Mitotane—CYP11A1—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	0.00203	0.00706	CbGpPWpGaD
Mitotane—Dysgeusia—Donepezil—Alzheimer's disease	0.00202	0.003	CcSEcCtD
Mitotane—Eye disorder—Memantine—Alzheimer's disease	0.00201	0.00299	CcSEcCtD
Mitotane—CYP11A1—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	0.002	0.00697	CbGpPWpGaD
Mitotane—Flushing—Memantine—Alzheimer's disease	0.002	0.00297	CcSEcCtD
Mitotane—CYP11A1—central nervous system—Alzheimer's disease	0.002	0.0586	CbGeAlD
Mitotane—SERPINA6—nervous system—Alzheimer's disease	0.00198	0.0579	CbGeAlD
Mitotane—Eye disorder—Rivastigmine—Alzheimer's disease	0.00197	0.00292	CcSEcCtD
Mitotane—CYP11A1—Biological oxidations—CYP46A1—Alzheimer's disease	0.00197	0.00685	CbGpPWpGaD
Mitotane—CYP11B1—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.00196	0.00682	CbGpPWpGaD
Mitotane—Flushing—Rivastigmine—Alzheimer's disease	0.00196	0.0029	CcSEcCtD
Mitotane—Angiopathy—Memantine—Alzheimer's disease	0.00195	0.0029	CcSEcCtD
Mitotane—Paraesthesia—Galantamine—Alzheimer's disease	0.00195	0.0029	CcSEcCtD
Mitotane—Vision blurred—Donepezil—Alzheimer's disease	0.00195	0.00289	CcSEcCtD
Mitotane—CYP11A1—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.00194	0.00676	CbGpPWpGaD
Mitotane—Tremor—Donepezil—Alzheimer's disease	0.00194	0.00287	CcSEcCtD
Mitotane—Somnolence—Galantamine—Alzheimer's disease	0.00193	0.00287	CcSEcCtD
Mitotane—CYP11B1—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.00192	0.00669	CbGpPWpGaD
Mitotane—Dyspepsia—Galantamine—Alzheimer's disease	0.00192	0.00284	CcSEcCtD
Mitotane—Angiopathy—Rivastigmine—Alzheimer's disease	0.00191	0.00284	CcSEcCtD
Mitotane—Anaemia—Donepezil—Alzheimer's disease	0.00191	0.00283	CcSEcCtD
Mitotane—SERPINA6—central nervous system—Alzheimer's disease	0.0019	0.0557	CbGeAlD
Mitotane—Decreased appetite—Galantamine—Alzheimer's disease	0.00189	0.00281	CcSEcCtD
Mitotane—Mental disorder—Memantine—Alzheimer's disease	0.00189	0.0028	CcSEcCtD
Mitotane—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00188	0.00279	CcSEcCtD
Mitotane—Malnutrition—Memantine—Alzheimer's disease	0.00188	0.00278	CcSEcCtD
Mitotane—SERPINA6—cerebellum—Alzheimer's disease	0.00186	0.0545	CbGeAlD
Mitotane—Vertigo—Donepezil—Alzheimer's disease	0.00186	0.00276	CcSEcCtD
Mitotane—Mental disorder—Rivastigmine—Alzheimer's disease	0.00185	0.00274	CcSEcCtD
Mitotane—Dysgeusia—Memantine—Alzheimer's disease	0.00184	0.00273	CcSEcCtD
Mitotane—Malnutrition—Rivastigmine—Alzheimer's disease	0.00183	0.00272	CcSEcCtD
Mitotane—CYP11B1—Corticotropin-releasing hormone—CRH—Alzheimer's disease	0.00181	0.00631	CbGpPWpGaD
Mitotane—Dysgeusia—Rivastigmine—Alzheimer's disease	0.0018	0.00267	CcSEcCtD
Mitotane—Feeling abnormal—Galantamine—Alzheimer's disease	0.00179	0.00266	CcSEcCtD
Mitotane—Hypertension—Donepezil—Alzheimer's disease	0.00178	0.00265	CcSEcCtD
Mitotane—Vision blurred—Memantine—Alzheimer's disease	0.00177	0.00262	CcSEcCtD
Mitotane—Tremor—Memantine—Alzheimer's disease	0.00176	0.00261	CcSEcCtD
Mitotane—Anaemia—Memantine—Alzheimer's disease	0.00173	0.00257	CcSEcCtD
Mitotane—Vision blurred—Rivastigmine—Alzheimer's disease	0.00173	0.00257	CcSEcCtD
Mitotane—Body temperature increased—Galantamine—Alzheimer's disease	0.00172	0.00255	CcSEcCtD
Mitotane—Tremor—Rivastigmine—Alzheimer's disease	0.00172	0.00255	CcSEcCtD
Mitotane—Confusional state—Donepezil—Alzheimer's disease	0.0017	0.00252	CcSEcCtD
Mitotane—Anaemia—Rivastigmine—Alzheimer's disease	0.0017	0.00252	CcSEcCtD
Mitotane—Vertigo—Memantine—Alzheimer's disease	0.00169	0.0025	CcSEcCtD
Mitotane—SHBG—Nongenotropic Androgen signaling—AKT1—Alzheimer's disease	0.00168	0.00585	CbGpPWpGaD
Mitotane—CYP11A1—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.00168	0.00584	CbGpPWpGaD
Mitotane—Infection—Donepezil—Alzheimer's disease	0.00168	0.00249	CcSEcCtD
Mitotane—Shock—Donepezil—Alzheimer's disease	0.00166	0.00246	CcSEcCtD
Mitotane—FDX1—Metabolism—DHCR24—Alzheimer's disease	0.00166	0.00576	CbGpPWpGaD
Mitotane—Nervous system disorder—Donepezil—Alzheimer's disease	0.00165	0.00245	CcSEcCtD
Mitotane—Thrombocytopenia—Donepezil—Alzheimer's disease	0.00165	0.00245	CcSEcCtD
Mitotane—Vertigo—Rivastigmine—Alzheimer's disease	0.00165	0.00245	CcSEcCtD
Mitotane—CYP11A1—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.00164	0.00572	CbGpPWpGaD
Mitotane—Hypertension—Memantine—Alzheimer's disease	0.00162	0.0024	CcSEcCtD
Mitotane—Anorexia—Donepezil—Alzheimer's disease	0.00161	0.00239	CcSEcCtD
Mitotane—Hypersensitivity—Galantamine—Alzheimer's disease	0.0016	0.00238	CcSEcCtD
Mitotane—SHBG—central nervous system—Alzheimer's disease	0.0016	0.047	CbGeAlD
Mitotane—CYP11A1—brain—Alzheimer's disease	0.00159	0.0465	CbGeAlD
Mitotane—Hypertension—Rivastigmine—Alzheimer's disease	0.00158	0.00235	CcSEcCtD
Mitotane—Hypotension—Donepezil—Alzheimer's disease	0.00158	0.00234	CcSEcCtD
Mitotane—SHBG—cerebellum—Alzheimer's disease	0.00157	0.0459	CbGeAlD
Mitotane—Asthenia—Galantamine—Alzheimer's disease	0.00156	0.00232	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.00155	0.0023	CcSEcCtD
Mitotane—CYP11A1—Corticotropin-releasing hormone—CRH—Alzheimer's disease	0.00155	0.00539	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	0.00154	0.00537	CbGpPWpGaD
Mitotane—Confusional state—Memantine—Alzheimer's disease	0.00154	0.00229	CcSEcCtD
Mitotane—Infection—Memantine—Alzheimer's disease	0.00152	0.00226	CcSEcCtD
Mitotane—Paraesthesia—Donepezil—Alzheimer's disease	0.00151	0.00225	CcSEcCtD
Mitotane—Confusional state—Rivastigmine—Alzheimer's disease	0.00151	0.00224	CcSEcCtD
Mitotane—SERPINA6—brain—Alzheimer's disease	0.00151	0.0442	CbGeAlD
Mitotane—Shock—Memantine—Alzheimer's disease	0.00151	0.00224	CcSEcCtD
Mitotane—Nervous system disorder—Memantine—Alzheimer's disease	0.0015	0.00223	CcSEcCtD
Mitotane—Somnolence—Donepezil—Alzheimer's disease	0.0015	0.00223	CcSEcCtD
Mitotane—Thrombocytopenia—Memantine—Alzheimer's disease	0.0015	0.00223	CcSEcCtD
Mitotane—Diarrhoea—Galantamine—Alzheimer's disease	0.00149	0.00221	CcSEcCtD
Mitotane—Infection—Rivastigmine—Alzheimer's disease	0.00149	0.00221	CcSEcCtD
Mitotane—Skin disorder—Memantine—Alzheimer's disease	0.00149	0.00221	CcSEcCtD
Mitotane—Dyspepsia—Donepezil—Alzheimer's disease	0.00148	0.0022	CcSEcCtD
Mitotane—Shock—Rivastigmine—Alzheimer's disease	0.00147	0.00219	CcSEcCtD
Mitotane—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.00147	0.00218	CcSEcCtD
Mitotane—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.00147	0.00218	CcSEcCtD
Mitotane—Decreased appetite—Donepezil—Alzheimer's disease	0.00147	0.00218	CcSEcCtD
Mitotane—Anorexia—Memantine—Alzheimer's disease	0.00146	0.00217	CcSEcCtD
Mitotane—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.00146	0.00216	CcSEcCtD
Mitotane—Skin disorder—Rivastigmine—Alzheimer's disease	0.00145	0.00216	CcSEcCtD
Mitotane—Pain—Donepezil—Alzheimer's disease	0.00144	0.00214	CcSEcCtD
Mitotane—Dizziness—Galantamine—Alzheimer's disease	0.00144	0.00214	CcSEcCtD
Mitotane—Hypotension—Memantine—Alzheimer's disease	0.00143	0.00212	CcSEcCtD
Mitotane—Anorexia—Rivastigmine—Alzheimer's disease	0.00143	0.00212	CcSEcCtD
Mitotane—FDX1—Metabolism—CA4—Alzheimer's disease	0.00141	0.0049	CbGpPWpGaD
Mitotane—Hypotension—Rivastigmine—Alzheimer's disease	0.0014	0.00208	CcSEcCtD
Mitotane—Feeling abnormal—Donepezil—Alzheimer's disease	0.00139	0.00206	CcSEcCtD
Mitotane—Vomiting—Galantamine—Alzheimer's disease	0.00138	0.00205	CcSEcCtD
Mitotane—CYP11A1—Prostaglandin Synthesis and Regulation—PTGS2—Alzheimer's disease	0.00138	0.0048	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	0.00138	0.00479	CbGpPWpGaD
Mitotane—Paraesthesia—Memantine—Alzheimer's disease	0.00137	0.00204	CcSEcCtD
Mitotane—CYP11B1—Biological oxidations—MAOB—Alzheimer's disease	0.00137	0.00478	CbGpPWpGaD
Mitotane—Rash—Galantamine—Alzheimer's disease	0.00137	0.00204	CcSEcCtD
Mitotane—Dermatitis—Galantamine—Alzheimer's disease	0.00137	0.00203	CcSEcCtD
Mitotane—Headache—Galantamine—Alzheimer's disease	0.00136	0.00202	CcSEcCtD
Mitotane—Somnolence—Memantine—Alzheimer's disease	0.00136	0.00202	CcSEcCtD
Mitotane—Dyspepsia—Memantine—Alzheimer's disease	0.00135	0.002	CcSEcCtD
Mitotane—Paraesthesia—Rivastigmine—Alzheimer's disease	0.00134	0.002	CcSEcCtD
Mitotane—Body temperature increased—Donepezil—Alzheimer's disease	0.00133	0.00198	CcSEcCtD
Mitotane—Somnolence—Rivastigmine—Alzheimer's disease	0.00133	0.00198	CcSEcCtD
Mitotane—Decreased appetite—Memantine—Alzheimer's disease	0.00133	0.00198	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	0.00132	0.00461	CbGpPWpGaD
Mitotane—FDX1—Metabolism—GAPDHS—Alzheimer's disease	0.00132	0.00461	CbGpPWpGaD
Mitotane—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.00132	0.00196	CcSEcCtD
Mitotane—Dyspepsia—Rivastigmine—Alzheimer's disease	0.00132	0.00196	CcSEcCtD
Mitotane—Pain—Memantine—Alzheimer's disease	0.00131	0.00194	CcSEcCtD
Mitotane—Decreased appetite—Rivastigmine—Alzheimer's disease	0.0013	0.00193	CcSEcCtD
Mitotane—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.00129	0.00192	CcSEcCtD
Mitotane—Nausea—Galantamine—Alzheimer's disease	0.00129	0.00192	CcSEcCtD
Mitotane—Pain—Rivastigmine—Alzheimer's disease	0.00128	0.0019	CcSEcCtD
Mitotane—SHBG—brain—Alzheimer's disease	0.00127	0.0373	CbGeAlD
Mitotane—Feeling abnormal—Memantine—Alzheimer's disease	0.00126	0.00187	CcSEcCtD
Mitotane—FDX1—Metabolism—ATP5A1—Alzheimer's disease	0.00126	0.00437	CbGpPWpGaD
Mitotane—Hypersensitivity—Donepezil—Alzheimer's disease	0.00124	0.00184	CcSEcCtD
Mitotane—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.00123	0.00183	CcSEcCtD
Mitotane—Body temperature increased—Memantine—Alzheimer's disease	0.00121	0.0018	CcSEcCtD
Mitotane—Asthenia—Donepezil—Alzheimer's disease	0.00121	0.0018	CcSEcCtD
Mitotane—FDX1—Metabolism—PLD3—Alzheimer's disease	0.0012	0.00417	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	0.0012	0.00417	CbGpPWpGaD
Mitotane—Body temperature increased—Rivastigmine—Alzheimer's disease	0.00118	0.00176	CcSEcCtD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	0.00118	0.00412	CbGpPWpGaD
Mitotane—CYP11A1—Biological oxidations—MAOB—Alzheimer's disease	0.00117	0.00409	CbGpPWpGaD
Mitotane—Diarrhoea—Donepezil—Alzheimer's disease	0.00115	0.00171	CcSEcCtD
Mitotane—FDX1—Metabolism—HSD17B10—Alzheimer's disease	0.00115	0.004	CbGpPWpGaD
Mitotane—Chlorphenamine—SLC6A4—Alzheimer's disease	0.00114	0.23	CrCbGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	0.00113	0.00395	CbGpPWpGaD
Mitotane—Hypersensitivity—Memantine—Alzheimer's disease	0.00113	0.00167	CcSEcCtD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	0.00112	0.00391	CbGpPWpGaD
Mitotane—Dizziness—Donepezil—Alzheimer's disease	0.00111	0.00166	CcSEcCtD
Mitotane—FDX1—Metabolism—CYP46A1—Alzheimer's disease	0.0011	0.00385	CbGpPWpGaD
Mitotane—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.0011	0.00164	CcSEcCtD
Mitotane—Asthenia—Memantine—Alzheimer's disease	0.0011	0.00163	CcSEcCtD
Mitotane—Asthenia—Rivastigmine—Alzheimer's disease	0.00107	0.0016	CcSEcCtD
Mitotane—Vomiting—Donepezil—Alzheimer's disease	0.00107	0.00159	CcSEcCtD
Mitotane—FDX1—Metabolism—ND1—Alzheimer's disease	0.00107	0.00371	CbGpPWpGaD
Mitotane—Rash—Donepezil—Alzheimer's disease	0.00106	0.00158	CcSEcCtD
Mitotane—Dermatitis—Donepezil—Alzheimer's disease	0.00106	0.00158	CcSEcCtD
Mitotane—Headache—Donepezil—Alzheimer's disease	0.00106	0.00157	CcSEcCtD
Mitotane—Diarrhoea—Memantine—Alzheimer's disease	0.00105	0.00155	CcSEcCtD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	0.00104	0.00363	CbGpPWpGaD
Mitotane—CYP11B1—Biological oxidations—PTGS1—Alzheimer's disease	0.00104	0.00362	CbGpPWpGaD
Mitotane—Diarrhoea—Rivastigmine—Alzheimer's disease	0.00102	0.00152	CcSEcCtD
Mitotane—CYP11B1—Biological oxidations—CYP2D6—Alzheimer's disease	0.00102	0.00355	CbGpPWpGaD
Mitotane—Dizziness—Memantine—Alzheimer's disease	0.00101	0.0015	CcSEcCtD
Mitotane—CYP11B1—Metapathway biotransformation—CYP2D6—Alzheimer's disease	0.00101	0.0035	CbGpPWpGaD
Mitotane—Nausea—Donepezil—Alzheimer's disease	0.001	0.00149	CcSEcCtD
Mitotane—Dizziness—Rivastigmine—Alzheimer's disease	0.00099	0.00147	CcSEcCtD
Mitotane—Vomiting—Memantine—Alzheimer's disease	0.000973	0.00144	CcSEcCtD
Mitotane—Rash—Memantine—Alzheimer's disease	0.000965	0.00143	CcSEcCtD
Mitotane—Dermatitis—Memantine—Alzheimer's disease	0.000964	0.00143	CcSEcCtD
Mitotane—Headache—Memantine—Alzheimer's disease	0.000959	0.00142	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	0.000958	0.00333	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	0.000954	0.00332	CbGpPWpGaD
Mitotane—Vomiting—Rivastigmine—Alzheimer's disease	0.000952	0.00141	CcSEcCtD
Mitotane—Rash—Rivastigmine—Alzheimer's disease	0.000944	0.0014	CcSEcCtD
Mitotane—Dermatitis—Rivastigmine—Alzheimer's disease	0.000943	0.0014	CcSEcCtD
Mitotane—Carbinoxamine—CYP2D6—Alzheimer's disease	0.000943	0.19	CrCbGaD
Mitotane—Headache—Rivastigmine—Alzheimer's disease	0.000938	0.00139	CcSEcCtD
Mitotane—Nausea—Memantine—Alzheimer's disease	0.000909	0.00135	CcSEcCtD
Mitotane—CYP11A1—Biological oxidations—PTGS1—Alzheimer's disease	0.00089	0.0031	CbGpPWpGaD
Mitotane—Nausea—Rivastigmine—Alzheimer's disease	0.00089	0.00132	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	0.000884	0.00308	CbGpPWpGaD
Mitotane—CYP11A1—Biological oxidations—CYP2D6—Alzheimer's disease	0.000873	0.00304	CbGpPWpGaD
Mitotane—CYP11A1—Metapathway biotransformation—CYP2D6—Alzheimer's disease	0.000861	0.003	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—GSK3B—Alzheimer's disease	0.000832	0.0029	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—CREB1—Alzheimer's disease	0.000825	0.00287	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	0.000822	0.00286	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	0.000819	0.00285	CbGpPWpGaD
Mitotane—Chlorphenamine—CYP2D6—Alzheimer's disease	0.000802	0.162	CrCbGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	0.000756	0.00263	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	0.000749	0.00261	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—NOS3—Alzheimer's disease	0.000719	0.0025	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—GSK3B—Alzheimer's disease	0.000712	0.00248	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—CREB1—Alzheimer's disease	0.000706	0.00246	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—BCL2—Alzheimer's disease	0.000693	0.00241	CbGpPWpGaD
Mitotane—FDX1—Metabolism—TPI1—Alzheimer's disease	0.000688	0.00239	CbGpPWpGaD
Mitotane—FDX1—Metabolism—CHAT—Alzheimer's disease	0.000688	0.00239	CbGpPWpGaD
Mitotane—FDX1—Metabolism—MAOB—Alzheimer's disease	0.000659	0.00229	CbGpPWpGaD
Mitotane—FDX1—Metabolism—GAPDH—Alzheimer's disease	0.000635	0.00221	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	0.000627	0.00218	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	0.000622	0.00216	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—NOS3—Alzheimer's disease	0.000615	0.00214	CbGpPWpGaD
Mitotane—FDX1—Metabolism—A2M—Alzheimer's disease	0.000613	0.00213	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—CASP3—Alzheimer's disease	0.000611	0.00213	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—BCL2—Alzheimer's disease	0.000593	0.00206	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—DHCR24—Alzheimer's disease	0.00059	0.00205	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—MAPK8—Alzheimer's disease	0.000561	0.00195	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	0.00055	0.00191	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	0.000547	0.0019	CbGpPWpGaD
Mitotane—FDX1—Metabolism—ACHE—Alzheimer's disease	0.000533	0.00186	CbGpPWpGaD
Mitotane—FDX1—Metabolism—INPP5D—Alzheimer's disease	0.000527	0.00183	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—CASP3—Alzheimer's disease	0.000523	0.00182	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—DHCR24—Alzheimer's disease	0.000505	0.00176	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CA4—Alzheimer's disease	0.000502	0.00175	CbGpPWpGaD
Mitotane—FDX1—Metabolism—ENO1—Alzheimer's disease	0.0005	0.00174	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PTGS1—Alzheimer's disease	0.0005	0.00174	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	0.00049	0.00171	CbGpPWpGaD
Mitotane—FDX1—Metabolism—CYP2D6—Alzheimer's disease	0.00049	0.00171	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—MAPK8—Alzheimer's disease	0.00048	0.00167	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—TGFB1—Alzheimer's disease	0.000476	0.00166	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GAPDHS—Alzheimer's disease	0.000472	0.00164	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	0.000471	0.00164	CbGpPWpGaD
Mitotane—FDX1—Metabolism—BCHE—Alzheimer's disease	0.000465	0.00162	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—ATP5A1—Alzheimer's disease	0.000447	0.00156	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PLCB1—Alzheimer's disease	0.000438	0.00153	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	0.00043	0.0015	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CA4—Alzheimer's disease	0.000429	0.00149	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PLD3—Alzheimer's disease	0.000427	0.00148	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	0.000427	0.00148	CbGpPWpGaD
Mitotane—FDX1—Metabolism—ABCA1—Alzheimer's disease	0.000425	0.00148	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	0.000422	0.00147	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	0.000419	0.00146	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—HSD17B10—Alzheimer's disease	0.000409	0.00142	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—TGFB1—Alzheimer's disease	0.000407	0.00142	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GAPDHS—Alzheimer's disease	0.000404	0.0014	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	0.0004	0.00139	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CYP46A1—Alzheimer's disease	0.000394	0.00137	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—ATP5A1—Alzheimer's disease	0.000383	0.00133	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—ND1—Alzheimer's disease	0.00038	0.00132	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	0.000372	0.00129	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PPARGC1A—Alzheimer's disease	0.000366	0.00127	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PLD3—Alzheimer's disease	0.000365	0.00127	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	0.000365	0.00127	CbGpPWpGaD
Mitotane—FDX1—Metabolism—HMOX1—Alzheimer's disease	0.000365	0.00127	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	0.000361	0.00126	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—HSD17B10—Alzheimer's disease	0.00035	0.00122	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	0.000342	0.00119	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	0.00034	0.00118	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CYP46A1—Alzheimer's disease	0.000337	0.00117	CbGpPWpGaD
Mitotane—FDX1—Metabolism—LPL—Alzheimer's disease	0.000333	0.00116	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—AKT1—Alzheimer's disease	0.000331	0.00115	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—ND1—Alzheimer's disease	0.000325	0.00113	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	0.000318	0.00111	CbGpPWpGaD
Mitotane—FDX1—Metabolism—MTHFR—Alzheimer's disease	0.0003	0.00104	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	0.000293	0.00102	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	0.000291	0.00101	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—AKT1—Alzheimer's disease	0.000283	0.000985	CbGpPWpGaD
Mitotane—FDX1—Metabolism—CALM1—Alzheimer's disease	0.00028	0.000976	CbGpPWpGaD
Mitotane—FDX1—Metabolism—APOE—Alzheimer's disease	0.000279	0.000973	CbGpPWpGaD
Mitotane—FDX1—Metabolism—CAV1—Alzheimer's disease	0.000277	0.000964	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	0.000267	0.000928	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	0.000251	0.000872	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CHAT—Alzheimer's disease	0.000245	0.000853	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—TPI1—Alzheimer's disease	0.000245	0.000853	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PPARG—Alzheimer's disease	0.000243	0.000847	CbGpPWpGaD
Mitotane—FDX1—Metabolism—INS—Alzheimer's disease	0.000239	0.000831	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—MAOB—Alzheimer's disease	0.000235	0.000818	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	0.000228	0.000794	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GAPDH—Alzheimer's disease	0.000226	0.000787	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	0.000224	0.000778	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	0.000221	0.000771	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—A2M—Alzheimer's disease	0.000218	0.00076	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—TPI1—Alzheimer's disease	0.00021	0.00073	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CHAT—Alzheimer's disease	0.00021	0.00073	CbGpPWpGaD
Mitotane—FDX1—Metabolism—NOS3—Alzheimer's disease	0.000209	0.000729	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—MAOB—Alzheimer's disease	0.000201	0.000699	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	0.000195	0.000678	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GAPDH—Alzheimer's disease	0.000193	0.000673	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PTGS2—Alzheimer's disease	0.000191	0.000667	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	0.000191	0.000666	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—ACHE—Alzheimer's disease	0.00019	0.000661	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	0.000189	0.00066	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—INPP5D—Alzheimer's disease	0.000188	0.000654	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—A2M—Alzheimer's disease	0.000187	0.00065	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—ENO1—Alzheimer's disease	0.000178	0.00062	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PTGS1—Alzheimer's disease	0.000178	0.00062	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CYP2D6—Alzheimer's disease	0.000175	0.000608	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	0.000167	0.00058	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—BCHE—Alzheimer's disease	0.000165	0.000576	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—ACHE—Alzheimer's disease	0.000163	0.000566	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—INPP5D—Alzheimer's disease	0.000161	0.000559	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PLCB1—Alzheimer's disease	0.000156	0.000544	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	0.000153	0.000533	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PTGS1—Alzheimer's disease	0.000152	0.00053	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—ENO1—Alzheimer's disease	0.000152	0.00053	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—ABCA1—Alzheimer's disease	0.000151	0.000527	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CYP2D6—Alzheimer's disease	0.000149	0.00052	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—BCHE—Alzheimer's disease	0.000142	0.000493	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PLCB1—Alzheimer's disease	0.000134	0.000465	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	0.000131	0.000456	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PPARGC1A—Alzheimer's disease	0.00013	0.000454	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—HMOX1—Alzheimer's disease	0.00013	0.000452	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—ABCA1—Alzheimer's disease	0.000129	0.000451	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—LPL—Alzheimer's disease	0.000119	0.000413	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PPARGC1A—Alzheimer's disease	0.000112	0.000388	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—HMOX1—Alzheimer's disease	0.000111	0.000387	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—MTHFR—Alzheimer's disease	0.000107	0.000372	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—LPL—Alzheimer's disease	0.000102	0.000354	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CALM1—Alzheimer's disease	9.99e-05	0.000348	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—APOE—Alzheimer's disease	9.96e-05	0.000347	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CAV1—Alzheimer's disease	9.86e-05	0.000343	CbGpPWpGaD
Mitotane—FDX1—Metabolism—AKT1—Alzheimer's disease	9.62e-05	0.000335	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—MTHFR—Alzheimer's disease	9.15e-05	0.000318	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PPARG—Alzheimer's disease	8.67e-05	0.000302	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CALM1—Alzheimer's disease	8.55e-05	0.000298	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—APOE—Alzheimer's disease	8.52e-05	0.000296	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—INS—Alzheimer's disease	8.51e-05	0.000296	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CAV1—Alzheimer's disease	8.44e-05	0.000294	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—NOS3—Alzheimer's disease	7.46e-05	0.00026	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PPARG—Alzheimer's disease	7.42e-05	0.000258	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—INS—Alzheimer's disease	7.28e-05	0.000253	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PTGS2—Alzheimer's disease	6.82e-05	0.000237	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—NOS3—Alzheimer's disease	6.38e-05	0.000222	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PTGS2—Alzheimer's disease	5.84e-05	0.000203	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—AKT1—Alzheimer's disease	3.43e-05	0.000119	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—AKT1—Alzheimer's disease	2.93e-05	0.000102	CbGpPWpGaD
